In September, the 19th China International Furniture Expo was held in the New International Expo Center. This exhibition brought together 3000 furniture enterprises from Europe、America and Asia. Tens of thousands of household products were unveiled. That products Include the high-tech equipment, wireless projection and wireless charging of office furniture and other new household products. A total of 232 overseas brands exhibitor attended this exhibition, Increase of 18% over last year. Design hall with comprehensive upgrade gathered nearly hundred design companies of original furniture in 2013. In addition to China's domestic famous original brands, such as ACF、HC28、Duma and so on, there were also overseas design new products from Germany, Australia, India, Indonesia, Singapore, Thailand, the Philippines and other countries. This exhibition offers various choices to buyers whose pursuit of creating unique lifestyle. After the successful hosting of world furniture meeting in 2012, there will be held three high-level meeting. They are respectively Chinese Furniture Marketing Meeting, Chinese Furniture Design Meeting and China Manufacturing Meeting. These meetings focus on the problem of the development of Chinese furniture industry, and give advice and suggestions to improve the overall level of Chinese furniture. Many furniture companies who were invited this exhibition start to join in science and technology exhibition. Taking the science and technology exhibition business mainly concentrated in the household industry and the real estate industry. Hundreds of furniture enterprises gathered in China International Furniture Expo. Facing intense competition of furniture exhibition, the enterprise in addition to work hard to make better products, and also need the aid of technology to promote their products. Of course, that is benefit for consumers and dealers. Because they can more intuitively feel products, also more likely to choose to suitable and excellent quality furniture for themselves. LUOYANG REDSING CORPORATION (GROUP).Was established in 1986. The one of large comprehensive Metal Office Furniture supplier and manufacturer, gathering development、design、manufacture、and sale in it, can produce 6 series, more than 500 various products such as: China shoe rack、Machine mess-shelf、 China office furniture、Book-shelf、File cabinet、Finance safe box、Office desk、School equipment and so on. Depend on its good quality, super after-sale service, the products selling well in domestic and Mongolia、Middle east、Russia、and Europe. Warmly welcome friends from home and abroad to our factory for a visit and negotiation for business with us.
You should choose the appropriate size of the shoe rack according to the size of the house‘s space, but it does not mean bigger is better. If you place a large shoe rack in a small space, it will give you have crowding feeling, if you have special requirements on the size, you can contact the factory to customize. You can choose the design of multi-storey shoe rack if you have many shoes, but preferably not more than five layers. When you are choosing the ordinary shoe rack, the first step is the attention of shoe rack’s surface, and you can touch the surface with your hand to feel it is smooth or not, gently press force point of each for testing whether firm. If the shoe rack has drawer, you should check the drawer slide and positioning, open all the doors and drawer, and ensure that they are properly installed without problems, and then check carefully the surface of the shoe rack whether has defiled streaks, the corner of polishing paint was coated uniform or not, and so on. If the purchase is disinfection shoe rack, you should pay attention to more places. First of all, pay attention to the material. If it is wood or density board, due to internal and external temperature is not balanced, will cause the deformation of the sheet and the shoe rack’s life is only a year; At the same time, if the internal heating will produce formaldehyde, it will have harm on human body, especially for young children and if it is serious will cause of blindness. So it's good to select the double-layer metal material of shoe rack. Intelligent shoe rack is a kind of high-tech products, so the technical requirements are higher. It is better to choose brand’s shoe rack, because some small factories maybe deceive consumers, they make the shoe shelf’s appearance is beautiful, but the interior is not practical. a high standard of the shoe rack’s interior is stainless steel. If intelligent shoe rack is working, you will smell the ozone smell when you open the door, and if you can also smell the distinct smell of ozone when you close the door, that mean ozone leakage, this shoe rack can’t be purchase. Finally, if you decide to purchase, you must ask whether there are reports of the national household electrical appliances inspection, how to solve the problem of using process, after sale service and other related issues, confirm and then make a purchase. LUOYANG REDSING CORPORATION (GROUP).Was established in 1986. The one of large comprehensive Metal Office Furniture supplier and manufacturer, gathering development、design、manufacture、and sale in it, can produce 6 series, more than 500 various products such as: China shoe rack、Machine mess-shelf、 China office furniture、Book-shelf、File cabinet、Finance safe box、Office desk、School equipment and so on. Depend on its good quality, super after-sale service, the products selling well in domestic and Mongolia、Middle east、Russia、and Europe. Warmly welcome friends from home and abroad to our factory for a visit and negotiation for business with us.
Nowadays, with improving the quality of people's lives, people have a higher standard for their health requirements. Thus, Shanghai office furniture also triggered a green storm. More and more people pay attention on healthcare in life daily. Of course, we also need to choose carefully the furniture, and prevent formaldehyde, mercury, benzene and other harmful substances exceeded and don’t let them affect our physical and mental health. But many consumers are only concerned about the choice of household furniture, but the selection of office furniture has not attracted widespread attention.
Most working people in the company office hours mostly in the eight hours or so, not including overtime, lunch time, etc. According to the strict calculation of each worker’s working time, they spend more than ten hours in their company, especially in the metropolis. Under the great pressure of work, working overtime is inevitable, the inferior office table, chair, office furniture will potential threat employees’ health for long time. Therefore, more and more office workers ask their boss to provide a safer and environmentally office furniture, which is the right to the protection of employees' health.
Therefore, the ensuing phenomenon is more and more humanized large enterprises addition price and functionality to the consideration of standard, and including the environmental protection, when they purchase office furniture. This not only reflects the humanity company, but also can enhance the centripetal force of employees, only protect the interests of employees, the company can better be developed.
In the green environmental protection has become the focus of our lives, we must also have environmentally conscious in our daily work. Along with this Green office furniture trend, it will bring us the best office mood, and unique taste of furniture. The office furniture industry is also bound to set off a wave of green boom.
LUOYANG REDSING CORPORATION (GROUP). Was established in 1986. The one of large comprehensive Metal Office Furniture supplier and manufacturer, gathering development、design、manufacture、and sale in it, can produce 6 series, more than 500 various products such as: China shoe rack、Machine mess-shelf、China office furniture、Book-shelf、File cabinet、Finance safe box、Office desk、School equipment and so on. Depend on its good quality, super after-sale service, the products selling well in domestic and Mongolia、Middle east、Russia、and Europe. Warmly welcome friends from home and abroad to our factory for a visit and negotiation for business with us.
Nowadays, with the rapid popularization of Internet, more SMEs see the upgrade of network marketing after the economic crisis. In past economic crisis, the Internet industry has minimum impact in all industry, and more surprising is that the network economy accelerating develops. Today, more and more SMEs join network marketing, including the class of office furniture. The following is analysis of current situation of office furniture network marketing in China.
First: The office furniture industry has characteristics of many product varieties、more product quantity and big demand, so these factors led office furniture become more difficult in network promotion and network marketing, the workload is relatively large in the early.
Second: Different regions of China have different modes, and the gap is relatively large. Like coastal areas which started earlier so the development is faster, the mainland areas which started late so the development is not fast. If there is no perfect sales promotion strategy, the country's largest market is difficult to be integrated and resulting in a waste of resources.
Third: Office furniture is mainly targeted at large quantities order from enterprises and institutions, this kind of people rarely have habits that search related information in the Internet, they are more inclined to the traditional mode of shopping.
Fourth: When it comes to e-commerce is associated with good logistics. If you want to do good in e-commerce, without a good logistics service is impossible. It is more important for office furniture to have good logistics. Because the threshold of office furniture products is lower, and there are many manufacturers, and the market is mainly in the local. So if you want to develop overseas customers, you should take more consideration in the factory and logistics. Founding a high-quality logistics team for delivering the goods is very important.
Fifth: Office furniture product varieties are many, but the style and the color are single, it cannot meet the demand of individual people. Developers should make efforts for the development of new furniture; furniture product should follow the times form, and cater to most people's preferences. The supplier should gradual eliminate of outdated products on the market. As a business manager, should be forethought and grasp the biggest trends, so can achieve long-term development of enterprises.
LUOYANG REDSING CORPORATION (GROUP). Was established in 1986. The one of large comprehensive Metal Office Furniture supplier and manufacturer, gathering development、design、manufacture、and sale in it, can produce 6 series, more than 500 various products such as: China shoe rack、Machine mess-shelf、China office furniture、Book-shelf、File cabinet、Finance safe box、Office desk、School equipment and so on. Depend on its good quality, super after-sale service, the products selling well in domestic and Mongolia、Middle east、Russia、and Europe. Warmly welcome friends from home and abroad to our factory for a visit and negotiation for business with us.
How should companies choose the right furniture? When companies choose and purchase office furniture, they will consider more details. Because office furniture can affect the company's whole image, and choosing the right furniture is an important link to build excellent company. The following are some small details about purchasing office furniture.
The first point: selection of office furniture, the first step is measuring the area of the office. Because the different nature of the office, selection of office furniture size is not the same, Office furniture should be compact; layout should be reasonable; make full use of limited office space.
The second point: purchasing office furniture should pay attention to the appearance modeling. Because it can directly display the image of an enterprise, and it represents the taste and grade of the entire enterprise. Of course you don't necessarily purchase expensive office furniture, because it doesn’t mean it has grades and taste. Generally speaking, choosing the brand office furniture should be right, but it is not mean entirely correct. Grade office furniture should be suitable for development direction of the company, and left the impression of generous and comfortable to the customer.
The third point: should pay attention to the quality of office furniture at the time of purchasing. Good quality office furniture will reflect its intrinsic value. So when you purchase the office furniture, negotiating with the merchant is an important link. To find a way to get lower prices is a profound knowledge, and at the same time, you should sign a contract and After-sales service guarantee.
The fourth point: in the procurement of office furniture, some large companies may choose the higher brand office furniture; because they think it will highlight the position of their company. However, for the early establishment of the company, it is more important to choose the practical and fashionable office furniture of low price.
LUOYANG REDSING CORPORATION (GROUP). Was established in 1986. The one of large comprehensive Metal Office Furniture supplier and manufacturer, gathering development、design、manufacture、and sale in it, can produce 6 series, more than 500 various products such as: China shoe rack、Machine mess-shelf、China office furniture、Book-shelf、File cabinet、Finance safe box、Office desk、School equipment and so on. Depend on its good quality, super after-sale service, the products selling well in domestic and Mongolia、Middle east、Russia、and Europe. Warmly welcome friends from home and abroad to our factory for a visit and negotiation for business with us.
Over the years, because of foreign "green barriers", traditional Chinese medicine export repeatedly rebuffed. China as a traditional Chinese medicine major power, Chinese medicine export volume accounts only for 3% to 5% in the world's traditional Chinese medicine market. Even more worrying is that foreign pharmaceutical companies import medicinal extracts from China, and do further processing in abroad, then turn it into " foreign Chinese medicine "and resold in high price.
According to the statistical data of China Chamber of Commerce for import and export of medicines and health products to display, plant extracts exports reached $330 million in the first quarter of 2013, an increase of 11.2%, accounting for 47% of the Chinese traditional medicine merchandise exports. Plant extracts in China export volume increasing year by year, it was $820 million in 2010, $1 billion in 2011, and reach to $1.16 billion in 2012. These plant extracts is processed into higher value-added "foreign Chinese medicine", and most of them were sold to the world's largest Chinese medicine consumption country -- China.
According to media reports, Jiuxindan is made in Japan Pharmaceutical Co. Ltd. , and it is developed on the basis of traditional Chinese medicine, and have implemented hundreds of millions of dollars a year in sales. The vast majority of those sales come from China. Germany imports large quantities of cheap ginkgo biloba from China every year, and then sold back to China in a higher price. According to incomplete statistics, "foreign Chinese medicine" has accounted for a third of the proprietary Chinese medicine market in China.
Due to successful experience of Japan Jiuxin Pharmaceutical Co. Ltd., more and more multinational companies are looking for the opportunities of traditional Chinese medicine to develop and invest. At the beginning of this year, the British FMCG giant Reckitt has announced the acquisition of Chinese medicine traditional Chinese medicine enterprises GuiLong.
Traditional Chinese medicine industry has been the traditional advantage industry in China, it has a long history of several thousand years, and it is the treasure of the Chinese nation. Over the years, traditional Chinese medicine traditional Chinese medicine with its yield, wide distribution, small toxic and side effect and other advantages occupy half of China's pharmaceutical industry. On the other hand, China lack of emphasis on traditional Chinese medicine industry. And traditional Chinese medicine industry technical standard system is not perfect, resulting in the slow development of traditional Chinese medicine industry and the internationalization of traditional Chinese medicine is difficult.
Rongda Pharm & Chem Co., Ltd is mainly involving in development, production and sales of pharm chemicals, fine chemicals, pharma intermediates, supplemented with AGRO chemicals. With the principle of 'to be honest, quality first, credit as our life”, we strive to make contributions to China pharm. And we will always try our best to provide our customer first class product. Warmly welcome friends from both home and abroad to cooperate with us.
According to The 20132017 Report of Demand and Supply and Competition in API market of Chinese Pharmaceutical Industry, the export of Chinese API was $12,112 thousand during the first half year of 2013, increasing by 3.08% and the accurate amount was 3,339.3 million tons, increasing by 7.46%. While the average export price decreased by 4.07%, the increasing rate was still low.
Nowadays, as the oversupply and the fierce competition in the market, as well as the slow economy recovery in developed countries and the currency devaluation in emerging market countries, it was hard to increase the export price of API. However, the growing cost of various aspects left little space for price decreasing.
One of the possible reasons for the oversupply of API was low demanding in technical request，easy to copy and no difference between products. Especially in the improvement of new GMP, it was easily to get to the point of oversupply of relatively low-tech products because of the fast investment in fixed assets. Thus decreasing the whole profit and causing vicious competition within the industry.
Another main reason to profit decreasing was a lack of capacity to solve environmental cost, especially with its rapid growth requirement. On one hand, all the cost was increasing. On the other hand, the price of terminal medicines was going down continuously, which brought about big difficulties to API firms. Moreover, the appreciation of the RMB also put stress on the export of API manufacturing and intermediate products with relatively low additional value.
Facing the depressed export market, pharmaceutical industry claimed to make effort to explore international market. Emphasis should be put on enlarging international market shares, participating in regional economic and trade cooperation actively, and finding solutions to various problems. Further, it should catch the opportunity to this new round of global pharmaceutical industry shift to Asian and enhance the transfer and absorption ability of global pharmaceutical industry.
Additionally, as the statistics showed: the export of Chinese API to emerging markets increased by 10.03%. Among this, large and medium pharmaceutical firms aimed to explore emerging and African markets greatly and the number of top pharmaceutical firms exporting to emerging markets increased by 12.2%. Under this fragile global economic and low demand of medicines circumstance, emerging markets was almost the only aim to Chinese API export.
Rongda Pharm & Chem Co., Ltd is mainly involving in development, production and sales of pharm chemicals, fine chemicals, pharma intermediates, supplemented with AGRO chemicals. With the principle of 'to be honest, quality first, credit as our life”, we strive to make contributions to China pharm. And we will always try our best to provide our customer first class product. Warmly welcome friends from both home and abroad to cooperate with us.
In recent years, China's BPC industry has developed rapidly and China has become the world's largest BPC producer and exporter. Currently, the foreign trade is still at the stage of constant growth with promising prospect. The constant progress of new medical system reform and supporting measures has promoted the industrial structure change of China's pharmaceutical manufacturing industry, which brings great opportunities for China's pharmaceutical industry. The prosperous industrial development provides favorable development opportunity for "CPhI, ICSE & BioPh China".
The exhibition will gather the most cutting-edge information of the pharmaceutical markets and present a comprehensive one-stop pharmaceutical industry trade platform for over 2,500 exhibitors and over 40,000 professional purchasers coming from more than 20 countries.
The meeting adopts the form of "display-meeting" to make the world timely grasp the latest news of Chinese and global pharmaceutical markets and create opportunities for further developing markets. In order to better promote the information interaction between the audience and enterprises, and satisfy the demand of the audience and enterprises for the latest industrial information and technological exchanges, the organizer during the exhibition will meticulously plan high-end forum, professional seminar, technological exchange symposium among exhibitors and purchase matching and other activities in terms of domestic and international latest policies, regulations, hot topics of the industry and practical technology application.
In order to protect IPR, the organizer will screen the product catalogue of all participating companies before the exhibition, forbid enterprises with infringing products to participate and protect the image of "Made in China" on the international stage. During the exhibition, it will establish exhibition intellectual property office on the site together with Shanghai Intellectual Property Administration to receive the complaints from the owners of intellectual property and deal with relevant matters. Meanwhile, the organizer will work with the drug supervision and administration department to conduct random check on the quality of on-spot exhibits.
At present, China Chamber of Commerce has formulated work solutions for resisting illegal drugs. It plans to use the exhibition platform to resist and crack down on illegal behaviors in partnership with the national drug supervision and administration department so as to maintain the industrial image and normal operation order.
Rongda Pharm & Chem Co., Ltd is mainly involving in development, production and sales of pharm chemicals, fine chemicals, pharma intermediates, supplemented with AGRO chemicals. With the principle of 'to be honest, quality first, credit as our life”, we strive to make contributions to China pharm. And we will always try our best to provide our customer first class product. Warmly welcome friends from both home and abroad to cooperate with us.
In recent years, with the continuous development of the pharmaceutical industry, the pharmaceutical trade export has become a focus of concern to the industry. Export trade appeared serious polarization, the developed market remains in the doldrums, and the demand of emerging market is strong.
According to relevant statistics show that the first half of this year the number of China's pharmaceutical products export to Europe and the United States, Japan and other developed markets is growth of 3.27%. It accounted for 55.26 percent export market share and compared with the same period last year decreased by 2 percentage points. A long-term double-digit growth of China pharm dressing export is end, and up only slightly by 1.01 percent. Currently, from basic data analysis: China's medical dressing industry as a whole showed the characteristics is small market size and product homogeneity; the industry concentration degree is low; the value-added is not high. Along with market competition heats up, the enterprise competition is mainly concentrated in terms of price competition, and the industry is in the low level competition stage.
However, the characteristic API exports increased rapidly, and formulations exports will usher in rapid growth period. According to incomplete statistics, in the first half, China's characteristic API exported $1.067 billion, up 11.23% from a year earlier. And exporting to India, the United States, the European Union, Japan and South Korea mainly accounted for more than 80% of the market. The first half of the year, western medicine preparation exported USD $ 1357000000, up 7.93% from a year earlier. The pharmaceutical preparations exports is expected would usher in a new period of rapid growth in the second half of this year.
In the export trade rising market, the momentum of Chinese medicine export increase is the most rapid. Exports amounted to $ 491 million, up 22.49%. These increases were mainly from exports of Chinese herbal medicine and extracts increased significantly. Among them, the domestic prices of Chinese herbal medicine are continuous rise in the past two years, and last year international customers reduced the purchase quantity, especially in Japan and South Korea and the ASEAN customers. Resulting in a decline in inventories in the first half of this year, which in turn increase the purchase quantity, and it will stimulate the prices are further increases at the same time. The first half of the year, Chinese export prices and export volume compared with the same period last year increased by 30.44%, 8.24%. it is expected that it will continue to maintain this favorable situation in the second half.
Many domestic pharmaceutical companies optimistic about this situation, choose the right direction, and prepare to enter the field. And further optimize the export structure, effectively stimulating the export of Chinese medicine products to further growth.
Rongda Pharm & Chem Co., Ltd is mainly involving in development, production and sales of pharm chemicals, fine chemicals, pharma intermediates, supplemented with AGRO chemicals. With the principle of 'to be honest, quality first, credit as our life”, we will always try our best to provide our customer first class product. Warmly welcome friends from both home and abroad to cooperate with us.
As a major exporter of API, China encountered many difficulties in entering the market in Europe and the United States. Recently, China Chamber of Commerce for Import of Medicine &Health Products (Hereinafter referred to as CCCMHPIE) introduced: the first half of the year, China's pharmaceutical import and export trade amounted to USD $43.237 billion. It’s Up 10.28% from a year earlier. But since the third quarter, China's API export to Europe and the United States perhaps will into the most difficult period. In the first half of this year, the global economic growth momentum is insufficient; the international market demand has not been radically improved, leading to the international pharmaceutical trade volume decreased. Against this background, the development situation of China pharm foreign trade is more severe. It is embodied as prominent overcapacity contradictions, the downward pressure of economy increased, Sluggish external demand and rising costs, increasing trade friction and so on. Meanwhile, the vice president of CCCMHPIE Xu Ming also admitted that China's pharmaceutical trades probably enter to a relatively long complicated period in the second half of this year. And the unstable and uncertain factors will increase. Especially the traditional API market in Europe and the United States nearly saturated, and the prices are low. When the market demand in Europe and the United States is still difficult to have markedly improved, China's API export to Europe and the United States perhaps will into the most difficult period CCCMHPIE analysis, the recent main characteristics of China's pharmaceutical trade is: The developed market remains in the doldrums; strong emerging market demand ; export structure was further optimized; export transformation tension is growth; medical equipment and characteristic API increased sharply; Cost advantage declines; weaken the market competitiveness of medical dressings and disposable supplies. ‘Against such a backdrop, Emerging markets become China's API exports increment the only way.’ Xu Ming said. Data show that the first half of China’s API exports to emerging markets increased 10.03%. Among them, the medium-sized pharmaceutical enterprises to increase efforts to develop emerging markets and African markets. The number of top 100 pharmaceutical enterprises exports to emerging markets is increased by 12.2%. Rongda Pharm & Chem Co., Ltd is mainly involving in development, production and sales of pharm chemicals, fine chemicals, pharma intermediates, supplemented with AGRO chemicals. With the principle of 'to be honest, quality first, credit as our life”, we will always try our best to provide our customer first class product.Warmly welcome friends from both home and abroad to cooperate with us.
|
RSS Feed